This data shows that PD mutations affect tau pathology in a mutation type specific manner, with both SNCA A53T and LRRK2 R1441G mutations having increased numbers of tau puncta in dopamine neurons, while PRKN lof did not display tau pathology. The gene discussed is PRKN; the disease is Parkinson disease.